Jagsonpal Pharmaceuticals share news, announcements and annual reports
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹230.96.
29 Oct: open ₹219.52, high ₹231.81, low ₹211.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,466 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 32.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 6.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.80%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,49,04126.1% delivered
Jagsonpal Pharmaceuticals board meetings
121 filed, newest first. Page 1 of 3.
Oct 2026
21 Oct · Board meeting
Jul 2026
Apr 2026
Mar 2026
12 Mar · Board meeting
9 Mar · Board meeting
Jan 2026
13 Jan · Board meeting
Oct 2025
27 Oct · Board meeting
Jul 2025
23 Jul · Board meeting
Apr 2025
Jan 2025
22 Jan · Board meeting
15 Jan · Board meeting
Oct 2024
Aug 2024
7 Aug · Board meeting
Jul 2024
May 2024
Feb 2024
2 Feb · Board meeting
Jan 2024
25 Jan · Board meeting
Nov 2023
3 Nov · Board meeting
Oct 2023
Aug 2023
2 Aug · Board meeting
Jul 2023
25 Jul · Board meeting
May 2023
Feb 2023
8 Feb · Board meeting
Jan 2023
31 Jan · Board meeting
Nov 2022
Aug 2022
May 2022
13 May · Board meeting
4 May · Board meeting
Feb 2022
11 Feb · Board meeting
3 Feb · Board meeting
Jan 2022
19 Jan · Board meeting
Not held on this date
Oct 2021
Aug 2021
13 Aug · Board meeting
4 Aug · Board meeting
Jun 2021
May 2021
25 May · Board meeting
14 May · Board meeting
Feb 2021
12 Feb · Board meeting
3 Feb · Board meeting
Nov 2020
10 Nov · Board meeting
Jul 2020
29 Jul · Board meeting
Feb 2020
13 Feb · Board meeting
3 Feb · Board meeting
Nov 2019
14 Nov · Board meeting